title: Lenalidomide-induced upregulation of CXCR4 in CD34+ hematopoietic cells, a potential mechanism of decreased hematopoietic progenitor mobilization.
authors.forename: S
authors.initials: S
authors.lastname: Li
authors.forename: J
authors.initials: J
authors.lastname: Fu
authors.forename: H
authors.initials: H
authors.lastname: Ma
authors.forename: M Y
authors.initials: MY
authors.lastname: Mapara
authors.forename: S
authors.initials: S
authors.lastname: Lentzsch
mesh_terms: D018952:Antigens, CD34 / Q000378:metabolism*; D005434:Flow Cytometry; D019650:Hematopoietic Stem Cell Mobilization; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D000077269:Lenalidomide; D019718:Receptors, CXCR4 / Q000378:metabolism*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000494:pharmacology; D015854:Up-Regulation / Q000187:drug effects*
chemical_list: D018952:Antigens, CD34; C527276:CXCR4 protein, human; D019718:Receptors, CXCR4; D013792:Thalidomide; D000077269:Lenalidomide